Ketamine shows promise for depression treatment in clinical trials
Ketamine may be one of the more widely used party drugs in the US, but it’s been building a solid medical case for patients suffering from extreme depression. Recent trial treatments in America using IV drips with micro-doses of Ketamine are proving to bolster users’ attitudes, with the drug’s effects notably being felt in a matter of minutes compared to other anti-depressants which typically take months or years.
Some patients, like Dennis Hartman from Seattle, swear by the potentially life-saving treatments telling The Washington Post, “My life will always be divided into the time before that first infusion and the time after. That sense of pain and suffering draining away. I was bewildered by the absence of pain.” Psychiatrist L. Alison McInnes dubbed it “the next big thing in psychiatry,” recommending the treatments to nearly 60 of her patients severely afflicted by depression. She claims to have seen a long-term success rate of about 60%.
It’s important to note the dosage quantity which is much less than one might consume in a social or party environment. The doses in these treatments are not enough to induce anaesthetic effects.
H/T: Stoney Roads